Susquehanna Portfolio Strategies’s Akero Therapeutics AKRO Stock Holding History

Susquehanna Portfolio Strategies’s Portfolio AKRO Stock Details AKRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-59,048	Closed	-$2.8M	–	995
2025 Q3	$2.8M	Buy	59,048 +43,292	+275%	+$2.1M	0.04%	439
2025 Q2	$841K	Buy	+15,756	New	+$716K	0.02%	546

Other funds holding AKRO

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Susquehanna Portfolio Strategies's AKRO Position: Q4 2025 in Review

Susquehanna Portfolio Strategies sold out of Akero Therapeutics (AKRO) in Q4 2025, closing a stake of 59,048 shares — an estimated $2.8M sold.

Susquehanna Portfolio Strategies first reported a position in AKRO in Q2 2025 and held it in 2 quarters. The position peaked at $2.8M in Q3 2025. 2 funds tracked by Wall St. Rank hold AKRO as of Q4 2025.

Susquehanna Portfolio Strategies reported no remaining Akero Therapeutics position as of Q4 2025 after selling out during the quarter.
Susquehanna Portfolio Strategies sold 59,048 Akero Therapeutics shares in Q4 2025, an estimated $2.8M.
Susquehanna Portfolio Strategies first reported a position in Akero Therapeutics in Q2 2025 and held it in 2 quarters.
Susquehanna Portfolio Strategies's Akero Therapeutics position peaked at $2.8M in Q3 2025.
2 funds tracked by Wall St. Rank held Akero Therapeutics as of Q4 2025.

Based on Susquehanna Portfolio Strategies's 13F filing for Q4 2025, filed 17 Feb 2026.